Mount Yale Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-107,635
Closed -$11.8M 345
2019
Q3
$11.8M Sell
107,635
-2,172
-2% -$206K 2.12% 2
2019
Q2
$10.3M Sell
109,807
-442
-0.4% -$42K 1.91% 4
2019
Q1
$10.4M Sell
110,249
-10,851
-9% -$949K 1.95% 3
2018
Q4
$10.9M Sell
121,100
-752
-0.6% -$55.5K 2.21% 2
2018
Q3
$9.2M Sell
121,852
-12,910
-10% -$1.14M 1.61% 4
2018
Q2
$10.7M Buy
134,762
+114,674
+571% +$9.52M 2.03% 2
2018
Q1
$1.79M Buy
+20,088
New +$1.93M 0.38% 69

Other funds holding CELG

Mount Yale Investment Advisors's CELG Position: Q4 2019 in Review

Mount Yale Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 107,635 shares — an estimated $11.8M sold.

Mount Yale Investment Advisors first reported a position in CELG in Q1 2018 and held it in 7 quarters. The position peaked at $11.8M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mount Yale Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 107,635 Celgene Corp shares in Q4 2019, an estimated $11.8M.
  • Mount Yale Investment Advisors first reported a position in Celgene Corp in Q1 2018 and held it in 7 quarters.
  • Mount Yale Investment Advisors's Celgene Corp position peaked at $11.8M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.